Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 6/2016

02.11.2015 | General Gynecology

Prevalence of uterine myomas in women in Germany: data of an epidemiological study

verfasst von: Hans-Joachim Ahrendt, Heike Tylkoski, Thomas Rabe, André Szczes, Cornelia Friedrich, Friedrich-Wilhelm Roehl, Ann Kitay, Thomas Roemer, Dolores Foth

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Currently, no reliable data are available concerning the prevalence of uterine myomas in Germany. In this prospective study, we examined the prevalence of myomas in women older than 30 years by means of vaginal ultrasound.

Methods

2296 women, who consented to the procedure, were examined by means of vaginal ultrasound for the presence of myomas in seven gynaecological outpatient departments in Germany.

Results

Prevalence: myomas were detected in 41.6 % of all women. Age dependence: With increasing age, the prevalence of uterine myomas rose from 21.3 % (30–35 years) to 62.8 % (46–50 years). Later, the number of myomas decreased again from 56.1 % (51–55 years) to 29.4 % in women older than 55 years. Menarche/BMI: no correlation could be found between the age at first menstrual period or the body mass index and the occurrence of myomas. Parity: since the group of nulliparous women and the group of women with more than four deliveries stand out by increased occurrence of myomas, a non-linear correlation seems to exist, necessitating more in-depth discussion with regard to age dependency.

Conclusions

The results of this study suggest that more than 40 % of women over 30 years of age suffered from myomas and more than 50 % of all women in Germany may develop uterine myomas at some time in their life.
Literatur
1.
Zurück zum Zitat Marshall LM, Spiegelman D, Goldman MB et al (1998) A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 70:432–439CrossRefPubMed Marshall LM, Spiegelman D, Goldman MB et al (1998) A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 70:432–439CrossRefPubMed
2.
Zurück zum Zitat Van Voorhis B (2009) A 41-year-old woman with menorrhagia, anemia, and fibroids: review of treatment of uterine fibroids. JAMA 301:82–93CrossRefPubMed Van Voorhis B (2009) A 41-year-old woman with menorrhagia, anemia, and fibroids: review of treatment of uterine fibroids. JAMA 301:82–93CrossRefPubMed
3.
Zurück zum Zitat Somigliana E, Vercellini P, Daguati R et al (2007) Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update 13:465–476CrossRefPubMed Somigliana E, Vercellini P, Daguati R et al (2007) Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update 13:465–476CrossRefPubMed
4.
Zurück zum Zitat Khan AT, Shehmar M, Gupta JK et al (2014) Uterine fibroids: current perspectives. Int J Women’s Health 6:95–114CrossRef Khan AT, Shehmar M, Gupta JK et al (2014) Uterine fibroids: current perspectives. Int J Women’s Health 6:95–114CrossRef
5.
Zurück zum Zitat Parker WH (2007) Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 87(4):725–736CrossRefPubMed Parker WH (2007) Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 87(4):725–736CrossRefPubMed
6.
Zurück zum Zitat Falcone T, Parker WH (2013) Surgical management of leiomyomas for fertility or uterine preservation. Obstet Gynecol 121(4):856–868CrossRefPubMed Falcone T, Parker WH (2013) Surgical management of leiomyomas for fertility or uterine preservation. Obstet Gynecol 121(4):856–868CrossRefPubMed
7.
Zurück zum Zitat Mecke H, Wallas F, Brocker A, Gertz HP (1995) Pelviscopic myomas enucleation: technique, limits, complications. Geburtshilfe Frauenheilkunde 55:374–379CrossRef Mecke H, Wallas F, Brocker A, Gertz HP (1995) Pelviscopic myomas enucleation: technique, limits, complications. Geburtshilfe Frauenheilkunde 55:374–379CrossRef
9.
Zurück zum Zitat Kröncke T, David M (2010) Uterusarterienembolisation zur Myombehandlung. Ergebnisse des III. Radiologisch-gynäkologischen Expertentreffens. Frauenarzt 51:644–648 Kröncke T, David M (2010) Uterusarterienembolisation zur Myombehandlung. Ergebnisse des III. Radiologisch-gynäkologischen Expertentreffens. Frauenarzt 51:644–648
10.
Zurück zum Zitat Bohlmann MK, Hunold P, Rabe T et al (2013) Neue diagnostische und therapeutische Optionen bei Patientinnen mit Myomen—Hochintensiver fokussierter Ultraschall. J Reproduktionsmed Endokrinol 10(5–6):266–272 Bohlmann MK, Hunold P, Rabe T et al (2013) Neue diagnostische und therapeutische Optionen bei Patientinnen mit Myomen—Hochintensiver fokussierter Ultraschall. J Reproduktionsmed Endokrinol 10(5–6):266–272
11.
Zurück zum Zitat Lethaby AE, Cooke I, Rees M (2005) Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 19:CD002126 Lethaby AE, Cooke I, Rees M (2005) Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 19:CD002126
12.
Zurück zum Zitat Islam MS, Protic O, Giannubilo SR et al (2013) Uterine leiomyoma: available medical treatments and new possible therapeutic options. J Clin Endocrinol Metab 98(3):921–934CrossRefPubMed Islam MS, Protic O, Giannubilo SR et al (2013) Uterine leiomyoma: available medical treatments and new possible therapeutic options. J Clin Endocrinol Metab 98(3):921–934CrossRefPubMed
13.
Zurück zum Zitat Donnez J, Tomaszewski J, Vazquez F, PEARL II Study Group et al (2012) Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 366:421–432CrossRefPubMed Donnez J, Tomaszewski J, Vazquez F, PEARL II Study Group et al (2012) Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 366:421–432CrossRefPubMed
14.
Zurück zum Zitat Yoshida S, Ohara N, Xu Q et al (2010) Celltype specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. Semin Reprod Med 28:260–273CrossRefPubMed Yoshida S, Ohara N, Xu Q et al (2010) Celltype specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. Semin Reprod Med 28:260–273CrossRefPubMed
15.
Zurück zum Zitat Donnez J, Tatarchuk TF, Bouchard P, PEARL I Study Group et al (2012) Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 366:409–420CrossRefPubMed Donnez J, Tatarchuk TF, Bouchard P, PEARL I Study Group et al (2012) Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 366:409–420CrossRefPubMed
16.
Zurück zum Zitat Baird DD, Dunson DB, Hill MC et al (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100–107CrossRefPubMed Baird DD, Dunson DB, Hill MC et al (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100–107CrossRefPubMed
17.
Zurück zum Zitat Cramer SF, Patel A (1990) The frequency of uterine leiomyomas. Am J Clin Pathol 94(4):435–438CrossRefPubMed Cramer SF, Patel A (1990) The frequency of uterine leiomyomas. Am J Clin Pathol 94(4):435–438CrossRefPubMed
18.
Zurück zum Zitat Chen CR, Buck GM, Courey NG et al (2001) Risk factors for uterine fibroids among women undergoing tubal sterilization. Am J Epidemiol 153(1):20–26CrossRefPubMed Chen CR, Buck GM, Courey NG et al (2001) Risk factors for uterine fibroids among women undergoing tubal sterilization. Am J Epidemiol 153(1):20–26CrossRefPubMed
19.
Zurück zum Zitat Marshall LM, Spiegelman D, Barbieri RL et al (1997) Variation in the incidence of uterine leiomyoma among pre-menopausal women by age and race. Obstet Gynecol 90:967–973CrossRefPubMed Marshall LM, Spiegelman D, Barbieri RL et al (1997) Variation in the incidence of uterine leiomyoma among pre-menopausal women by age and race. Obstet Gynecol 90:967–973CrossRefPubMed
20.
Zurück zum Zitat Hartmann KE, Birnbaum H, Ben Hamadi R et al (2006) Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol 108(4):930–937CrossRefPubMed Hartmann KE, Birnbaum H, Ben Hamadi R et al (2006) Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol 108(4):930–937CrossRefPubMed
21.
Zurück zum Zitat Wenderlein JM (2012) Hysterektomie-Häufigkeit variiert in Bundesländern bis um den Faktor 2. Frauenarzt 53(5):481–488 Wenderlein JM (2012) Hysterektomie-Häufigkeit variiert in Bundesländern bis um den Faktor 2. Frauenarzt 53(5):481–488
22.
Zurück zum Zitat Marsh EE, Ekpo GE, Cardozo ER et al (2013) Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18–30 years old): a pilot study. Fertil Steril 99(7):1951–1957CrossRefPubMedPubMedCentral Marsh EE, Ekpo GE, Cardozo ER et al (2013) Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18–30 years old): a pilot study. Fertil Steril 99(7):1951–1957CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Baird DD, Schectman JM, Dixon D et al (1998) African Americans at higher risk than whites for uterine fibroids: ultrasound evidence. Am J Epidemiol 147:S9 Baird DD, Schectman JM, Dixon D et al (1998) African Americans at higher risk than whites for uterine fibroids: ultrasound evidence. Am J Epidemiol 147:S9
24.
Zurück zum Zitat Faerstein E, Szklo M, Rosenshein N (2001) Risk factors for uterine leiomyoma: a practice based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol 153(1):1–10CrossRefPubMed Faerstein E, Szklo M, Rosenshein N (2001) Risk factors for uterine leiomyoma: a practice based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol 153(1):1–10CrossRefPubMed
25.
Zurück zum Zitat Borgfeldt C et al (2000) Transvaginal ultrasonographic findings in the uterus and Endometrium: low prevalence of leiomyoma in a random sample of women age 25–40 years. Acta Obstet Gynecol Scand 79:202–207CrossRefPubMed Borgfeldt C et al (2000) Transvaginal ultrasonographic findings in the uterus and Endometrium: low prevalence of leiomyoma in a random sample of women age 25–40 years. Acta Obstet Gynecol Scand 79:202–207CrossRefPubMed
26.
Zurück zum Zitat Lurie S, Piper I, Woliowitch I, Glezerman M (2005) Age-related prevalence of sonographicaly confirmed uterine myomas. J Obstet Gynaecol 25(1):42–43CrossRefPubMed Lurie S, Piper I, Woliowitch I, Glezerman M (2005) Age-related prevalence of sonographicaly confirmed uterine myomas. J Obstet Gynaecol 25(1):42–43CrossRefPubMed
27.
Zurück zum Zitat Marino JL, Eskenazi B, Warner M et al (2004) Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod 19(10):2350–2355 (Epub 2004 Jul 8) CrossRefPubMed Marino JL, Eskenazi B, Warner M et al (2004) Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod 19(10):2350–2355 (Epub 2004 Jul 8) CrossRefPubMed
28.
Zurück zum Zitat Yan L, Ding L, Li C et al (2014) Effect of fibroids not distorting the endometrial cavity on the outcome of in vitro fertilization treatment: a retrospective cohort study. Fertil Steril 101(3):716–721CrossRefPubMed Yan L, Ding L, Li C et al (2014) Effect of fibroids not distorting the endometrial cavity on the outcome of in vitro fertilization treatment: a retrospective cohort study. Fertil Steril 101(3):716–721CrossRefPubMed
29.
Zurück zum Zitat Kjerulff KH, Langenberg P, Seidman JD et al (1996) Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 41:483–490PubMed Kjerulff KH, Langenberg P, Seidman JD et al (1996) Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 41:483–490PubMed
30.
Zurück zum Zitat Wegienka G, Baird DD, Hertz-Picciotto I et al (2003) Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol 101:431–437PubMed Wegienka G, Baird DD, Hertz-Picciotto I et al (2003) Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol 101:431–437PubMed
31.
Zurück zum Zitat Ekin M, Cengiz H, Öztürk E et al (2014) Genitourinary symptoms and their effects on quality of life in women with uterine myomas. Int Urogynecol J 25(6):807–810CrossRefPubMed Ekin M, Cengiz H, Öztürk E et al (2014) Genitourinary symptoms and their effects on quality of life in women with uterine myomas. Int Urogynecol J 25(6):807–810CrossRefPubMed
32.
Zurück zum Zitat Laughlin SK, Schroeder JC, Baird DD (2010) New directions in the epidemiology of uterine fibroids. Semin Reprod Med 28(3):204–217CrossRefPubMed Laughlin SK, Schroeder JC, Baird DD (2010) New directions in the epidemiology of uterine fibroids. Semin Reprod Med 28(3):204–217CrossRefPubMed
33.
Zurück zum Zitat Mäkinen N, Heinonen HR, Moore S et al (2011) MED12 exon 2 mutations are common in uterine leiomyomas from South African patients. Oncotarget 2(12):966–969CrossRefPubMedPubMedCentral Mäkinen N, Heinonen HR, Moore S et al (2011) MED12 exon 2 mutations are common in uterine leiomyomas from South African patients. Oncotarget 2(12):966–969CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Yin P, Lin Z, Reierstad S et al (2010) Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells. Cancer Res 70:1722–1730CrossRefPubMedPubMedCentral Yin P, Lin Z, Reierstad S et al (2010) Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells. Cancer Res 70:1722–1730CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Lobel MK, Somasundaam P, Morton CC (2006) The genetic heterogeneity of uterine leiomyomata. Obstet Gynecol Clin North Am 33:13–39CrossRefPubMed Lobel MK, Somasundaam P, Morton CC (2006) The genetic heterogeneity of uterine leiomyomata. Obstet Gynecol Clin North Am 33:13–39CrossRefPubMed
36.
Zurück zum Zitat Wei JJ, Chiriboga L, Mittal K (2005) Expression profile of the tumorigenic factors associated with tumour size and sex steroid hormone status in uterine leiomyomata. Fertil Steril 84:474–484CrossRefPubMed Wei JJ, Chiriboga L, Mittal K (2005) Expression profile of the tumorigenic factors associated with tumour size and sex steroid hormone status in uterine leiomyomata. Fertil Steril 84:474–484CrossRefPubMed
37.
Zurück zum Zitat Okolo S (2008) Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 22(4):571–588CrossRefPubMed Okolo S (2008) Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 22(4):571–588CrossRefPubMed
38.
Zurück zum Zitat Parazzini F, Negri E, La Vecchia C et al (1996) Reproductive factors and risk of uterine fibroids. Epidemiology 7:440–442CrossRefPubMed Parazzini F, Negri E, La Vecchia C et al (1996) Reproductive factors and risk of uterine fibroids. Epidemiology 7:440–442CrossRefPubMed
39.
Zurück zum Zitat Lauren A, Palmer JR, Harlow BL et al (2004) Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African–American women: a prospective study. Am J Epidemiol 159:113–123CrossRef Lauren A, Palmer JR, Harlow BL et al (2004) Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African–American women: a prospective study. Am J Epidemiol 159:113–123CrossRef
40.
41.
Zurück zum Zitat Velez Edwards DR, Baird DD, Hartmann KE (2013) Association of age at menarche with increasing number of fibroids in a cohort of women who underwent standardized ultrasound assessment. Am J Epidemiol 178(3):426–433. doi:10.1093/aje/kws585 Epub 2013 Jun 30 CrossRefPubMedPubMedCentral Velez Edwards DR, Baird DD, Hartmann KE (2013) Association of age at menarche with increasing number of fibroids in a cohort of women who underwent standardized ultrasound assessment. Am J Epidemiol 178(3):426–433. doi:10.​1093/​aje/​kws585 Epub 2013 Jun 30 CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Wise LA, Palmer JR, Spiegelman D et al (2005) Influence of body size and body fat distribution on risk of uterine leiomyomata in US black women. Epidemiology 16:346–354CrossRefPubMedPubMedCentral Wise LA, Palmer JR, Spiegelman D et al (2005) Influence of body size and body fat distribution on risk of uterine leiomyomata in US black women. Epidemiology 16:346–354CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Shikora SA, Niloff JM, Bistrian BR et al (1991) Relationship between obesity and uterine leiomyomata. Nutrition 7:251–255PubMed Shikora SA, Niloff JM, Bistrian BR et al (1991) Relationship between obesity and uterine leiomyomata. Nutrition 7:251–255PubMed
46.
Zurück zum Zitat Ross RK, Pke MC, Vessey MP et al (1986) Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) 293:359–362CrossRef Ross RK, Pke MC, Vessey MP et al (1986) Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) 293:359–362CrossRef
47.
Zurück zum Zitat Samadi AR, Lee NC, Flanders WD et al (1996) Risk factors for self-reported uterine fibroids: a case–control study. Am J Public Health 86:858–862CrossRefPubMedPubMedCentral Samadi AR, Lee NC, Flanders WD et al (1996) Risk factors for self-reported uterine fibroids: a case–control study. Am J Public Health 86:858–862CrossRefPubMedPubMedCentral
Metadaten
Titel
Prevalence of uterine myomas in women in Germany: data of an epidemiological study
verfasst von
Hans-Joachim Ahrendt
Heike Tylkoski
Thomas Rabe
André Szczes
Cornelia Friedrich
Friedrich-Wilhelm Roehl
Ann Kitay
Thomas Roemer
Dolores Foth
Publikationsdatum
02.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 6/2016
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-015-3930-8

Weitere Artikel der Ausgabe 6/2016

Archives of Gynecology and Obstetrics 6/2016 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.